
    
      All participants will receive itraconazole during their inpatient post transplant stay. As an
      outpatient, ten subjects will be randomized to receive itraconazole 200mg orally once daily
      for 6 month and ten patients to receive voriconazole 200mg orally twice daily for 6 months .
      All subjects will be followed in the clinic as per the standard transplant treatment
    
  